2-tert-butylhydroquinone has been researched along with Diabetes Mellitus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, C; Liu, K; Ren, Y; Sui, X; Wang, Z; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and Diabetes Mellitus
| Article | Year |
|---|---|
Integrating network pharmacology, transcriptomics, and molecular simulation to reveal the mechanism of tert-butylhydroquinone for treating diabetic retinopathy.
Topics: Antioxidants; Diabetes Mellitus; Diabetic Retinopathy; Humans; Hydroquinones; Network Pharmacology; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Transcriptome; Vascular Endothelial Growth Factor A | 2022 |